Delivery Order SPE2DX22D0129-SPE2D826F0BLA
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,544.40 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger prime indefinite delivery vehicle, represents a non-competitive set-aside award for pharmaceutical and medical supply fulfillment. The vendor, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $272,697.60 to AmerisourceBergen Drug Corp on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies to support federal military and healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,939.94 to AmerisourceBergen Drug Corp on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical products and medical supplies to support federal medical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,094.70 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply delivery to support federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $81,049.50 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,171.48 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,126.93 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract action for pharmaceutical and medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BLADelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $53,650.50 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's comprehensive medical supply operations. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains—to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a strategic pharmaceutical provider within the DLA's evolving Pharmaceutical Prime Vendor Global Program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.7k | 11/17/25 |